Nexium Φακελίσκοσ (Esomeprazole)

Esomeprazole, the active ingredient in Nexium Φακελίσκοσ, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease and as part of Helicobacter pylori eradication regimens in adult patients.

GNH USA supplies Nexium Φακελίσκοσ as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Esomeprazole acts on the gastric acid‑secretion pathway and is indicated for several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): reduces acid exposure and promotes healing of the oesophageal mucosa. - Erosive esophagitis: facilitates ulcer healing and symptom relief. - Peptic ulcer disease: supports ulcer closure and prevents recurrence. - Helicobacter pylori eradication: used in combination therapy to improve eradication rates.

Adverse reactions may occur with esomeprazole therapy.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: loose stools occurring intermittently. - Nausea: sensation of stomach upset. - Abdominal pain: discomfort in the upper abdomen. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent diarrhoea with abdominal pain. - Low magnesium levels: muscle cramps, weakness, or irregular heartbeat. - Elevated liver enzymes: signs of hepatic stress. - Stevens‑Johnson syndrome: severe skin blistering. - Acute pancreatitis: sudden upper abdominal pain with nausea.

Before initiating therapy, consider the following safety measures. - Renal function assessment: adjust use in patients with severe impairment. - Elderly patients: monitor for increased sensitivity to side effects. - Long‑term use: evaluate necessity regularly to avoid unnecessary exposure. - Magnesium monitoring: check levels during prolonged therapy. - Concomitant medication review: assess for potential interactions. - Store at ambient temperature: keep in the original pack, protect from moisture.

Esomeprazole may affect the pharmacokinetics of several drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing clot risk. - Atazanavir: decreased antiviral absorption, compromising efficacy. - Ketoconazole: markedly reduced antifungal absorption.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum concentrations, risk of toxicity. - Methotrexate: elevated levels may enhance toxicity, especially at high doses.